Salus (FRA:E3U) Cyclically Adjusted Revenue per Share: €61.68 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:E3U Salus FRA:E3U
75 GF Score
Price €65.00
GF Value €31.75
! 4 Warning Signs
View Full Analysis

What is Salus Cyclically Adjusted Revenue per Share?

Salus FRA:E3U -1.52% 75 Cyclically Adjusted Revenue per Share is €61.68 as of Mar. 2026. GuruFocus rates FRA:E3U with a GF Score™ of 75/100 and a GF Value™ of €31.75. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Salus's adjusted revenue per share for the three months ended in Mar. 2026 was €23.890. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €61.68 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Salus's average Cyclically Adjusted Revenue Growth Rate was 12.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-29), Salus's current stock price is €65.00. Salus's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €61.68. Salus's Cyclically Adjusted PS Ratio of today is 1.05.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Salus was 1.19. The lowest was 0.39. And the median was 0.52.


Salus  (FRA:E3U) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Salus's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=65.00/61.68
=1.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Salus was 1.19. The lowest was 0.39. And the median was 0.52.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Salus Cyclically Adjusted Revenue per Share Related Terms


Salus Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Salus's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Salus Cyclically Adjusted Revenue per Share Chart

Salus Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 58.18

Salus Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 58.18 61.68

FRA:E3U vs MCK, COR, CAH: Cyclically Adjusted Revenue per Share Comparison

For the Medical Distribution subindustry, Salus's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Salus Cyclically Adjusted PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Salus's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Salus's Cyclically Adjusted PS Ratio falls into.


FRA:E3U
75GF Score
Salus FRA:E3U
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Salus Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Salus's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=23.89/330.2130*330.2130
=23.890

Current CPI (Mar. 2026) = 330.2130.

Salus Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 7.061 241.018 9.674
201609 7.031 241.428 9.617
201612 7.230 241.432 9.889
201703 6.968 243.801 9.438
201706 7.435 244.955 10.023
201709 7.363 246.819 9.851
201712 7.794 246.524 10.440
201803 7.826 249.554 10.355
201806 8.441 251.989 11.061
201809 7.593 252.439 9.932
201812 8.299 251.233 10.908
201903 10.351 254.202 13.446
201906 10.832 256.143 13.964
201909 10.122 256.759 13.018
201912 11.439 256.974 14.699
202003 12.325 258.115 15.768
202006 11.255 257.797 14.417
202009 12.328 260.280 15.640
202012 13.307 260.474 16.870
202103 13.137 264.877 16.377
202106 13.577 271.696 16.501
202109 13.821 274.310 16.638
202112 15.754 278.802 18.659
202203 15.445 287.504 17.739
202206 14.944 296.311 16.654
202209 14.791 296.808 16.456
202212 15.705 296.797 17.473
202303 17.311 301.836 18.938
202306 17.850 305.109 19.319
202309 17.923 307.789 19.229
202312 20.160 306.746 21.702
202403 20.027 312.332 21.174
202406 19.026 314.175 19.997
202409 19.206 315.301 20.114
202412 20.642 315.605 21.597
202503 20.261 319.799 20.921
202506 20.605 322.561 21.094
202509 20.318 324.800 20.657
202512 23.533 324.054 23.980
202603 23.890 330.213 23.890

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €61.68 mean?
Salus (FRA:E3U) has a Cyclically Adjusted Revenue per Share of €61.68 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Salus and its competitors.
Is Salus' Cyclically Adjusted Revenue per Share too high?
Salus' current Cyclically Adjusted Revenue per Share is €61.68. Overall, Salus has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Salus' Cyclically Adjusted Revenue per Share compare to MCK and COR?
Salus' Cyclically Adjusted Revenue per Share of €61.68 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Distribution company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Salus and its competitors. Salus's current Cyclically Adjusted Revenue per Share is €61.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Salus stock overvalued right now?
Salus (FRA:E3U) has a current Cyclically Adjusted Revenue per Share of €61.68. The stock's GF Value™ is €31.75, compared to a current price of €65.00 — trading 104.7% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €61.68. Salus' overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Salus (FRA:E3U), the current Cyclically Adjusted Revenue per Share is €61.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Salus (FRA:E3U) Overvalued in 2026?

Based on GuruFocus' analysis, Salus stock appears to be overvalued. The current stock price of €65.00 is trading 104.7% above its estimated GF Value™ of €31.75.

Key valuation signals for FRA:E3U:

  • Cyclically Adjusted Revenue per Share: €61.68
  • GF Value™: €31.75 vs. price of €65.00 (104.7% above fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the FRA:E3U stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Salus Business Description

Other Exchanges SALR:Slovenia
Address Litostrojska cesta 46 A, Ljubljana, SVN, 1000
Salus is a Slovenia-based company engaged in the wholesale and distribution of medical products. It offers medicines, medical devices, medical supplies, dietary supplements, cosmetics to hospitals, pharmacies, and other customers.
75GF Score

Get the complete analysis for FRA:E3U

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€65.00
Price
€31.75
GF Value